Estimaciones de analistas de Wall Street para Celularity Inc. (CELU): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 3 |
| Mantener | 2 |
| Venta | 1 |
| Venta fuerte | 0 |
| Analistas totales | 6 |
| Calificación media (1-5) | 0.33 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-13 | |||
| 2026-08-31 | |||
| 2026-05-08 | |||
| 2026-04-30 | $-0.95 | $-1.50 | +36.7% |
| 2025-11-14 | $-0.88 | $-1.50 | +41.3% |
| 2025-08-29 | $-0.75 | ||
| 2025-05-08 | $-0.84 | $-1.50 | +44.0% |
| 2024-12-06 | $-0.73 | $-1.40 | +47.9% |
Ratios de valoración
| Precio / Valor contable | -0.73 |
| EV / EBITDA | -0.91 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | $17.6M | $21.1M | $14.3M | $21.3M | $18.0M | $22.8M | $54.2M | $26.6M |
| Coste de Ventas | $6.6M | $6.3M | $4.9M | $9.7M | $19.7M | $16.0M | $15.0M | $6.4M |
| Beneficio Bruto | $11.0M | $14.8M | $9.3M | $11.7M | -$1.7M | $6.8M | $39.2M | $20.2M |
| I+D | $29.1M | $46.1M | $52.7M | $88.4M | $78.4M | $30.5M | $17.4M | $15.0M |
| Generales y Administrativos | $1098 | $41.8M | $31.3M | $71.3M | $66.0M | $50.6M | $58.6M | $51.3M |
| Gastos Operativos | $1098 | $279.0M | $161.3M | $120.7M | $23.9M | $199.0M | $77.6M | $81.5M |
| Beneficio Operativo | -$1098 | -$264.1M | -$151.9M | -$109.1M | -$25.6M | -$192.3M | -$38.4M | -$61.3M |
| EBITDA | -$1098 | -$71.0M | -$202.4M | -$88.1M | -$138.8M | -$183.9M | -$43.7M | -$77.7M |
| Gastos por Intereses | 0 | 0 | $2.4M | $3.2M | 0 | $3.0M | $6.3M | $6.8M |
| Beneficio Antes de Impuestos | -$1098 | -$268.0M | -$212.9M | -$100.1M | $14.2M | -$196.3M | -$57.9M | -$91.7M |
| Impuestos | 0 | -$56.1M | -$4.7M | $20000 | $13000 | $10000 | 0 | $3000 |
| Beneficio Neto | -$1098 | -$211.9M | -$208.2M | -$100.1M | $14.2M | -$196.3M | -$57.9M | -$91.8M |
| BPA | $0.00 | $-88.75 | $-113.06 | $-7.87 | $1.01 | $-11.02 | $-2.64 | $-3.59 |
| BPA Diluido | $0.00 | $-88.75 | $-113.06 | $-7.87 | $0.95 | $-11.02 | $-2.64 | $-3.59 |
| Acciones en Circulación (Diluidas) | $3.6M | $2.4M | $1.8M | $12.7M | $15.0M | $17.8M | $21.9M | $25.6M |
Precio
| Precio | $1.29 |
| Capitalización | $37M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ANVS · ATNM · BCAB · BTAI · FGEN · GBIO · KZR
Explorar sector: Healthcare · Biotechnology
Más secciones de CELU: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones